BRAINSTORM CELL THERAPEUTICS INC.

Analyst Reco. Brainstorm Cell Therapeutics Inc. Deutsche Boerse AG

Equities

GHDN

US10501E2019

Delayed Deutsche Boerse AG Other stock markets 02:20:41 2024-07-12 am EDT			5-day change	1st Jan Change
0.3585 ^EUR	+17.16%		+15.83%	+55.87%

Jul. 11	Maxim Upgrades Brainstorm Cell Therapeutics to Buy From Hold, Price Target is $2	MT
Jul. 08	Transcript : Brainstorm Cell Therapeutics Inc. - Special Call

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Maxim Upgrades Brainstorm Cell Therapeutics to Buy From Hold, Price Target is $2	Jul. 11	MT
Brainstorm Cell Therapeutics Prices Registered Direct Offering, Concurrent Private Placement	Jun. 27	MT
Maxim Downgrades Brainstorm Cell Therapeutics to Hold From Buy	23-09-28	MT
Maxim Group Adjusts Price Target on Brainstorm Cell Therapeutics to $10 From $5, Maintains Buy Rating	23-03-31	MT
BRAINSTORM CELL THERAPEUTICS : Maxim Group Upgrades Brainstorm Cell Therapeutics to Buy From Hold	21-02-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer